Fine Foods & Pharmaceuticals N.T.M Bilan de santé

Santé financière contrôle des critères 5/6

Fine Foods & Pharmaceuticals N.T.M possède un total de capitaux propres de €130.5M et une dette totale de €56.4M, ce qui porte son ratio d'endettement à 43.2%. Son actif total et son passif total sont €232.0M et de €101.4M. L'EBIT de Fine Foods & Pharmaceuticals N.T.M est €15.2M ce qui fait que son ratio de couverture des intérêts 4.7. Elle dispose de liquidités et de placements à court terme de €9.1M.

Informations clés

43.2%

Ratio d'endettement

€56.44m

Dette

Ratio de couverture des intérêts	4.7x
Argent liquide	€9.06m
Fonds propres	€130.55m
Total du passif	€101.41m
Total des actifs	€231.96m

Mises à jour récentes de la santé financière

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Recent updates

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Sep 20

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Apr 28

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Mar 20

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

Feb 22

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

Feb 01

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

Jan 14

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Dec 28

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de FF ( €91.7M ) dépassent ses passifs à court terme ( €62.3M ).

Passif à long terme: Les actifs à court terme de FF ( €91.7M ) dépassent ses passifs à long terme ( €39.2M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de FF ( 36.3% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de FF est passé de 21.1% à 43.2% au cours des 5 dernières années.

Couverture de la dette: La dette de FF est bien couverte par le flux de trésorerie opérationnel ( 74.1% ).

Couverture des intérêts: Les paiements d'intérêts de FF sur sa dette sont bien couverts par l'EBIT ( 4.7 x couverture).

Fine Foods & Pharmaceuticals N.T.M Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Recent updates

Third quarter 2024 earnings released

New major risk - Revenue and earnings growth

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Second quarter 2024 earnings released

Now 20% undervalued

Upcoming dividend of €0.12 per share

First quarter 2024 earnings released

Now 20% undervalued after recent price drop

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2023 earnings released

Second quarter 2023 earnings released

New major risk - Revenue and earnings growth

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) commences an Equity Buyback Plan for 20% of its issued share capital,under the authorization approved on May 9, 2023.

First quarter 2023 earnings released

Upcoming dividend of €0.10 per share at 1.3% yield

Less than half of directors are independent

Consensus forecasts updated

Price target decreased to €11.50

Second quarter 2022 earnings released

First quarter 2022 earnings: Revenues in line with analyst expectations

Upcoming dividend of €0.16 per share

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Price target decreased to €14.25

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Now 30% undervalued after recent price drop

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) made an offer to acquire an additional 24.94% stake in Euro Cosmetic Spa (BIT:EC) for €10.2 million.

Price target decreased to €20.50

Third quarter 2021 earnings released

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) signed a binding agreement to acquire a 72.9% stake in Euro Cosmetic S.p.A. (BIT:EC) from Findea's Srl and MD S.R.L. for €26.8 million.

First half 2021 earnings released: €0.26 loss per share

Price target increased to €18.50

Upcoming dividend of €0.14 per share

Full year 2020 earnings released: EPS €0.58 (vs €0.12 loss in FY 2019)

Price target increased to €15.50

Price target increased to €14.90

Consensus EPS estimates fall to €0.52

Full year 2020 earnings released: EPS €0.58 (vs €0.34 in FY 2019)

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Fine Foods & Pharmaceuticals N.T.M. S.p.A. to Report Fiscal Year 2020 Results on Apr 12, 2021

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Price target raised to €13.50

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

New 90-day high: €11.30

New 90-day low: €9.76

First half earnings released

New 90-day low: €10.45

New 90-day high - €11.10

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines